Emergence of Institutional Antithrombotic Protocols for Coronavirus 2019

Overview

Journal Res Pract Thromb Haemost

Publisher Elsevier

Date 2020 Jun 17

PMID 32542211

Citations 38

Authors

Kevin P Cohoon

Guillaume Mahe

Alfonso J Tafur

Alex C Spyropoulos

Affiliations

Soon will be listed here.

Citing Articles

Anticoagulant therapy in COVID-19: A narrative review.

Mohseni Afshar Z, Tavakoli Pirzaman A, Hosseinzadeh R, Babazadeh A, Taghizadeh Moghadam M, Miri S Clin Transl Sci. 2023; 16(9):1510-1525.

PMID: 37326220 PMC: 10499427. DOI: 10.1111/cts.13569.

Prevalence and Risk Factors of Venous Thromboembolism in Critically Ill Patients with Severe COVID-19 and the Association between the Dose of Anticoagulants and Outcomes.

Al-Dorzi H, Alqirnas M, Hegazy M, Alghamdi A, Alotaibi M, Albogami M J Crit Care Med (Targu Mures). 2022; 8(4):249-258.

PMID: 36474613 PMC: 9682926. DOI: 10.2478/jccm-2022-0023.

Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH.

Spyropoulos A, Connors J, Douketis J, Goldin M, Hunt B, Kotila T J Thromb Haemost. 2022; 20(10):2226-2236.

PMID: 35906715 PMC: 9349985. DOI: 10.1111/jth.15809.

Immuno-Thrombotic Complications of COVID-19: Implications for Timing of Surgery and Anticoagulation.

Bunch C, Moore E, Moore H, Neal M, Thomas A, Zackariya N Front Surg. 2022; 9:889999.

PMID: 35599794 PMC: 9119324. DOI: 10.3389/fsurg.2022.889999.

Low versus high dose anticoagulation in patients with Coronavirus 2019 pneumonia at the time of admission to critical care units: A multicenter retrospective cohort study in the Beaumont healthcare system.

Al-Banaa K, Alshami A, Elhouderi E, Hannoodee S, Hannoodee M, Al-Hillan A PLoS One. 2022; 17(3):e0265966.

PMID: 35325001 PMC: 8947132. DOI: 10.1371/journal.pone.0265966.

References

Mousavi S, Moradi M, Khorshidahmad T, Motamedi M . Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review. Adv Pharmacol Sci. 2015; 2015:507151. PMC: 4443644. DOI: 10.1155/2015/507151. View

Freeman A, Pendleton R, Rondina M . Prevention of venous thromboembolism in obesity. Expert Rev Cardiovasc Ther. 2010; 8(12):1711-21. PMC: 3245959. DOI: 10.1586/erc.10.160. View

Heit J, OFallon W, Petterson T, Lohse C, Silverstein M, Mohr D . Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002; 162(11):1245-8. DOI: 10.1001/archinte.162.11.1245. View

Zhang H, Penninger J, Li Y, Zhong N, Slutsky A . Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020; 46(4):586-590. PMC: 7079879. DOI: 10.1007/s00134-020-05985-9. View

Arabi Y, Balkhy H, Hayden F, Bouchama A, Luke T, Baillie J . Middle East Respiratory Syndrome. N Engl J Med. 2017; 376(6):584-594. PMC: 5362064. DOI: 10.1056/NEJMsr1408795. View

Smeeth L, Cook C, Thomas S, Hall A, Hubbard R, Vallance P . Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006; 367(9516):1075-1079. DOI: 10.1016/S0140-6736(06)68474-2. View

Lew T, Kwek T, Tai D, Earnest A, Loo S, Singh K . Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA. 2003; 290(3):374-80. DOI: 10.1001/jama.290.3.374. View

Huang W, Goldberg R, Anderson F, Kiefe C, Spencer F . Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009). Am J Med. 2014; 127(9):829-39.e5. PMC: 4161646. DOI: 10.1016/j.amjmed.2014.03.041. View

Klok F, Kruip M, van der Meer N, Arbous M, Gommers D, Kant K . Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191:145-147. PMC: 7146714. DOI: 10.1016/j.thromres.2020.04.013. View

10.

Hull R, Schellong S, Tapson V, Monreal M, Samama M, Nicol P . Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med. 2010; 153(1):8-18. DOI: 10.7326/0003-4819-153-1-201007060-00004. View

11.

Rogers M, Levine D, Blumberg N, Flanders S, Chopra V, Langa K . Triggers of hospitalization for venous thromboembolism. Circulation. 2012; 125(17):2092-9. PMC: 3342773. DOI: 10.1161/CIRCULATIONAHA.111.084467. View

12.

Amin A, Varker H, Princic N, Lin J, Thompson S, Johnston S . Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients. J Hosp Med. 2011; 7(3):231-8. DOI: 10.1002/jhm.1002. View

13.

Miranda S, Le Cam-Duchez V, Benichou J, Donnadieu N, Barbay V, Le Besnerais M . Adjusted value of thromboprophylaxis in hospitalized obese patients: A comparative study of two regimens of enoxaparin: The ITOHENOX study. Thromb Res. 2017; 155:1-5. DOI: 10.1016/j.thromres.2017.04.011. View

14.

Yao X, Li T, He Z, Ping Y, Liu H, Yu S . [A pathological report of three COVID-19 cases by minimal invasive autopsies]. Zhonghua Bing Li Xue Za Zhi. 2020; 49(5):411-417. DOI: 10.3760/cma.j.cn112151-20200312-00193. View

15.

Cohoon K, De Sanctis Y, Haskell L, McBane R, Spiro T . Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study. J Thromb Haemost. 2018; 16(7):1278-1287. DOI: 10.1111/jth.14146. View

16.

Lippi G, Plebani M, Henry B . Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020; 506:145-148. PMC: 7102663. DOI: 10.1016/j.cca.2020.03.022. View

17.

Schmidt M, Horvath-Puho E, Thomsen R, Smeeth L, Sorensen H . Acute infections and venous thromboembolism. J Intern Med. 2011; 271(6):608-18. PMC: 3505369. DOI: 10.1111/j.1365-2796.2011.02473.x. View

18.

Lippi G, Favaloro E . D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Thromb Haemost. 2020; 120(5):876-878. PMC: 7295300. DOI: 10.1055/s-0040-1709650. View

19.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

20.

Kahn S, Lim W, Dunn A, Cushman M, Dentali F, Akl E . Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl):e195S-e226S. PMC: 3278052. DOI: 10.1378/chest.11-2296. View